Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Return on Sales (2016 - 2025)

Historic Return on Sales for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to 0.16%.

  • Prestige Consumer Healthcare's Return on Sales fell 500.0% to 0.16% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.17%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.19% for FY2025, which is 0.0% changed from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Return on Sales of 0.16% as of Q4 2025, which was down 500.0% from 0.15% recorded in Q3 2025.
  • Prestige Consumer Healthcare's Return on Sales' 5-year high stood at 0.21% during Q2 2021, with a 5-year trough of 0.84% in Q1 2023.
  • Its 5-year average for Return on Sales is 0.13%, with a median of 0.19% in 2024.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Return on Sales crashed by -10400bps in 2023 and then skyrocketed by 10200bps in 2024.
  • Prestige Consumer Healthcare's Return on Sales (Quarter) stood at 0.18% in 2021, then increased by 3bps to 0.19% in 2022, then decreased by 0bps to 0.19% in 2023, then increased by 12bps to 0.21% in 2024, then dropped by -22bps to 0.16% in 2025.
  • Its Return on Sales stands at 0.16% for Q4 2025, versus 0.15% for Q3 2025 and 0.19% for Q2 2025.